Last week (30th October) the Chancellor announced the opening of a new Life Sciences Innovative Manufacturing Fund (LSIMF) which will provide up to £520 million in capital grants to help UK’s medicines manufacturers grow and innovate. It builds on the success of former schemes that unlocked hundreds of millions of pounds of private investment and secured or created thousands of jobs across the UK.
This fund will back companies investing in life sciences manufacturing projects and aims to drive growth and building resilience for future health emergencies.
Life Sciences has been earmarked as one of the eight key sectors that will drive long-term, sustainable, and resilient growth nationwide, and will form the focus of the upcoming Industrial Strategy.
If you would like to discuss the above and/or apply to the new fund, please click here for further information.
Presentation: Applicant Guidance
